PTGS2 and squamous cell carcinoma: Although many studies have suggested the potential benefit of Cox-2 inhibition, especially in the prevention of colon cancer, whether suppression of this enzyme can be preventative or therapeutic for squamous cell carcinomas (SCCs) remains unclear.